Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia

Chemico-Biological Interactions

Volumn 228, Issue , 2015, Pages 79-87

  Miao, Hua ^a,b   Chen, Hua ^a   Pei, Songwen ^d   Bai, Xu ^c   Vaziri, Nosratola D ^b   Zhao, Ying Yong ^a,b  

^a NORTHWEST UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Waters Technologies Shanghai Ltd   (China)

^d UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

Author keywords

High fat diet; High definition mass spectrometry; Hyperlipidemia; Lipid abnormality; Lipidomics; Ultra performance liquid chromatography

Indexed keywords

CHOLESTEROL; FATTY ACID; GLYCEROLIPID; GLYCEROPHOSPHOLIPID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSANOID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPHINGOLIPID; TRIACYLGLYCEROL;

ADVERSE EFFECTS; ANALYTIC METHOD; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISCRIMINANT ANALYSIS; DOWN REGULATION; HEATMAP ANALYSIS; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPIDOMICS; MALE; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PLASMA LIPIDOMICS; RAT; SPRAGUE DAWLEY RAT; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION;

ADVERSE EFFECTS; ANIMALS; BLOOD; DIET, HIGH-FAT; FATTY ACIDS; GLYCEROPHOSPHOLIPIDS; HYPERLIPIDEMIAS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOLIPIDS;

RATTUS;

EID: 84941280138     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.01.023     Document Type: Article

References (48)

1. E. Esteve, W. Ricart, and J.M. Fernández-Real Dyslipidemia and inflammation: an evolutionary conserved mechanism Clin. Nutr. 24 2005 16 31
2. J.H. O'Keefe, and D.S.H. Bell Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor Am. J. Cardiol. 100 2007 899 904
3. K. Siemianowicz Laboratory diagnosis of lipid imbalance Wiad. Lek. 49 1996 159 162
4. F. Spener, M. Lagarde, A. Geloen, and M. Record What is lipidomics? Eur. J. Lipid Sci. Technol. 105 2003 481 482
5. P.J. Meikle, G. Wong, C.K. Barlow, and B.A. Kingwell Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease Pharmacol. Ther. 143 2014 12 23
6. Y.Y. Zhao, X.L. Cheng, and R.C. Lin Lipidomics applications for discovering biomarkers of diseases in clinical chemistry Int. Rev. Cell Mol. Biol. 313 2014 1 26
7. H. Chen, H. Miao, Y.L. Feng, Y.Y. Zhao, and R.C. Lin Metabolomics in dyslipidemia Adv. Clin. Chem. 66 2014 101 119
8. W. Yin, E. Carballo-Jane, D.G. McLaren, V.H. Mendoza, K. Gagen, N.S. Geoghagen, L.A. McNamara, J.N. Gorski, G.J. Eiermann, A. Petrov, M. Wolff, X. Tong, L.C. Wilsie, T.E. Akiyama, J. Chen, A. Thankappan, J. Xue, X. Ping, G. Andrews, L.A. Wickham, C.L. Gai, T. Trinh, A.A. Kulick, M.J. Donnelly, G.O. Voronin, R. Rosa, A.M. Cumiskey, K. Bekkari, L.J. Mitnaul, O. Puig, F. Chen, R. Raubertas, P.H. Wong, B.C. Hansen, K.S. Koblan, T.P. Roddy, B.K. Hubbard, and A.M. Strack Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia J. Lipid Res. 53 2012 51 65
9. F. Chen, V. Maridakis, E.A. O'Neill, B.K. Hubbard, A. Strack, C. Beals, G.A. Herman, and P. Wong The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidemia Biomarkers 16 2011 321 333
10. G. Stübiger, E. Aldover-Macasaet, W. Bicker, G. Sobal, A. Willfort-Ehringer, K. Pock, V. Bochkov, K. Widhalm, and O. Belgacem Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS Atherosclerosis 224 2012 177 186
11. H. Miao, H. Chen, X. Zhang, L. Yin, D.Q. Chen, X.L. Cheng, X. Bai. F. Wei, Urinary metabolomics on the biochemical profiles in diet-induced hyperlipidemia rat using ultra-performance liquid-chromatography coupled with quadrupole time-of-flight synapt high-definition mass spectrometry, J. Anal. Methods Chem. 2014 (2014) 184162.
12. Y.Y. Zhao, S.P. Wu, S. Liu, Y. Zhang, and R.C. Lin Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications Chem. Biol. Interact. 220 2014 181 192
13. E application in disease biomarker discovery: the discoveries in proteomics to metabolomics Chem. Biol. Int. 215 2014 7 16
14. I.D. Wilson, J.K. Nicholson, J. Castro-Perez, J.H. Granger, K.A. Johnson, B.W. Smith, and R.S. Plumb High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies J. Proteome Res. 4 2005 591 598
15. X. Wang, H. Sun, A. Zhang, P. Wang, and Y. Han Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies J. Sep. Sci. 34 2011 3451 3459
16. Y.Y. Zhao, J. Liu, X.L. Cheng, X. Bai, and R.C. Lin Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS Clin. Chim. Acta 413 2012 642 649
17. M. Wrona, T. Mauriala, K.P. Bateman, R.J. Mortishire-Smith, and D. O'Connor 'All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching Rapid Commun. Mass Spectrom. 19 2005 2597 2602
18. E-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one Chem. Biol. Interact. 301 2013 31 38
19. E data collection technique Biomarkers 17 2012 721 729
20. E J. Proteome Res. 12 2013 692 703
21. Y.T. Liu, J.B. Peng, H.M. Jia, D.Y. Cai, H.W. Zhang, C.Y. Yu, and Z.M. Zou UPLC-Q/TOF MS standardized Chinese formula Xin-Ke-Shu for the treatment of atherosclerosis in a rabbit model Phytomedicine 21 2014 1364 1372
22. S. Subramaniam, E. Fahy, S. Gupta, M. Sud, R.W. Byrnes, D. Cotter, A.R. Dinasarapu, and M.R. Maurya Bioinformatics and systems biology of the lipidome Chem. Rev. 111 2011 6452 6490
23. E. Fahy, S. Subramaniam, R.C. Murphy, M. Nishijima, C.R. Raetz, T. Shimizu, F. Spener, G. van Meer, M.J. Wakelam, and E.A. Dennis Update of the LIPID MAPS comprehensive classification system for lipids J. Lipid Res. 50 2009 S9 S14
24. P.T. Ivanova, S.B. Milne, M.O. Byrne, Y. Xiang, and H.A. Brown Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry Methods Enzymol. 432 2007 21 57
25. T. Matsumoto, T. Kobayashi, and K. Kamata Role of lysophosphatidylcholine (LPC) in atherosclerosis Curr. Med. Chem. 14 2007 3209 3220
26. J.B. Peng, H.M. Jia, Y.T. Liu, H.W. Zhang, S. Dong, and Z.M. Zou Qualitative and quantitative characterization of chemical constituents in Xin-Ke-Shu preparations by liquid chromatography coupled with a LTQ Orbitrap mass spectrometer J. Pharm. Biomed. Anal. 55 2011 984 995
27. J. Frostegård Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease Clin. Immunol. 134 2010 47 54
28. 1H NMR based metabonomics approach to progression of coronary atherosclerosis in a rabbit model Process Biochem. 46 2011 2240 2247
29. J.M. Castro-Perez, T.P. Roddy, V. Shah, D.G. McLaren, S.P. Wang, K. Jensen, R.J. Vreeken, T. Hankemeier, D.G. Johns, S.F. Previs, and B.K. Hubbard Identifying static and kinetic lipid phenotypes by high resolution UPLC-MS: unraveling diet-induced changes in lipid homeostasis by coupling metabolomics and fluxomics J. Proteome Res. 10 2011 4281 4290
30. F. Zhang, Z. Jia, P. Gao, H. Kong, X. Li, J. Chen, Q. Yang, P. Yin, J. Wang, X. Lu, F. Li, Y. Wu, and G. Xu Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry Talanta 79 2009 836 844
31. M. Reimann, M. Peitzsch, T. Ziemssen, U. Julius. G. Eisenhofer, Metabolomic distinction of microvascular effects of lipoprotein apheresis - a pilot study, Atheroscler. Suppl. 14 (2013) 143-149.
32. Q. Zhang, G.J. Wang, Y. Du, B. Xiang, H. Deng, J. A., B. Ma, Application of several pattern recognition methods in metabonomic research of rat hyperlipidemia, J. China Pharm. Univ. 40 (2009) 448-453.
33. W.H. Liu, Q. Zhang, X.Z. Yan, L. Wang, and F. Yu Metabonomics study on phlegm and blood stasis evolution of hyperlipidemia and atherosclerosis J. Trad. Chin. Med. 49 2008 738 741
34. D.L. Tang, L. Tong, H.M. Zhang, Y. Sui, and H.F. Cui Experimental study of the phlegm and blood stasis recipe on serum lipids and metabolomics in the hyperlipidemia myocardial ischemia reperfusion injury rats Chin. J. Basic Med. Trad. Chin. Med. 19 2013 41 43
35. Y. Zhao, W. Jia, M.M. Su, Y.P. Qiu, and X.P. Wang Novel biomarkers of hyperlipidemic acute pancreatitis: metabolomic identification As. Biomed. 6 2012 765 769
36. D. Bai, and J.N. Song Plasma metabolic biomarkers for syndrome of phlegm and blood stasis in hyperlipidemia and atherosclerosis J. Trad. Chin. Med. 32 2012 578 583
37. Q. Zhang, G.J. Wang, J.Y. A, D. Wu, L.L. Zhu, B. Ma, and Y. Du Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats Acta Pharmacol. Sin. 30 2009 1674 1687
38. H.Y. Kwan, Y.M. Hu, C.L. Chan, H.H. Cao, C.Y. Cheng, S.Y. Pan, K.W. Tse, Y.C. Wu, Z.L. Yu, and W.F. Fong Lipidomics identification of metabolic biomarkers in chemically induced hypertriglyceridemic mice J. Proteome Res. 12 2013 1387 1398
39. S.H. Gu, G. Wang, W. Zha, B. Yan, Y. Zhang, H. Ren, B. Cao, and L. Liu Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia Biomed. Chromatogr. 24 2010 245 252
40. A.A. Toye, M.E. Dumas, C. Blancher, A.R. Rothwell, J.F. Fearnside, S.P. Wilder, M.T. Bihoreau, O. Cloarec, I. Azzouzi, S. Young, R.H. Barton, E. Holmes, M.I. McCarthy, R. Tatoud, J.K. Nicholson, J. Scott, and D. Gauguier Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice Diabetologia 50 2007 1867 1879
41. R.S. Tilvis, and T.A. Miettinen Serum plant sterols and their relation to cholesterol absorption Am. J. Clin. Nutr. 43 1986 92 97
42. R. Kleemann, L. Verschuren, M.J. van Erk, Y. Nikolsky, N.H. Cnubben, E.R. Verheij, A.K. Smilde, H.F. Hendriks, S. Zadelaar, G.J. Smith, V. Kaznacheev, T. Nikolskaya, A. Melnikov, E. Hurt-Camejo, J. van der Greef, B. van Ommen, and T. Kooistra Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis Genome Biol. 8 2007 R200
43. A.M. Katz, and F.C. Messineo Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium Circ. Res. 48 1981 1 16
44. M.E. Venable, J.Y. Lee, M.J. Smyth, A. Bielawska, and L.M. Obeid Role of ceramide in cellular senescence J. Biol. Chem. 270 1995 30701 30708
45. C. Pavoine, and F. Pecker Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology Cardiovasc. Res. 82 2009 175 183
46. T.S. Worgall, R.A. Juliano, T. Seo, and R.J. Deckelbaum Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein Arterioscler. Thromb. Vasc. Biol. 24 2004 943 948
47. K.A. Rye, N.J. Hime, and P.J. Barter The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins J. Biol. Chem. 271 1996 4243 4250
48. C. Rodriguez-Lafrasse, R. Rousson, P.G. Pentchev, P. Louisot, and M.T. Vanier Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders Biochim. Biophys. Acta 1226 1994 138 144